Max Healthcare Institute Limited (MAXHEALTH.BO)
INR 1196.5
(0.28%)
INR 1196.5
(0.28%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 11.02 Billion | 12.09 Billion | 7.4 Billion | 1.17 Billion | 770.9 Million | 889.5 Million |
| Net Income | 10.57 Billion | 10.63 Billion | 7.38 Billion | -686.5 Million | 127.8 Million | 83.2 Million |
| Depreciation & Amortization | 2.44 Billion | 2.32 Billion | 2.21 Billion | 1.74 Billion | 456.4 Million | 1.02 Billion |
| Deferred income taxes | - | -1.78 Billion | -1.46 Billion | 549.9 Million | - | - |
| Stock-based compensation | 496.2 Million | 343.6 Million | 339.3 Million | 265.1 Million | - | - |
| Change in working capital | -1.59 Billion | 806.3 Million | -1.3 Billion | -3.76 Billion | -388.4 Million | -481.3 Million |
| Other non-cash items | 5.92 Billion | -228.2 Million | 240.2 Million | 3.07 Billion | 575.1 Million | 261.2 Million |
| Investing Cash Flow | -14.38 Billion | -11.87 Billion | -7.63 Billion | -730 Million | -26.4 Billion | -165.3 Million |
| Investments in PPE | -7.78 Billion | -3.35 Billion | -5.53 Billion | -1.18 Billion | -900.9 Million | -1.15 Billion |
| Acquisitions | -6.23 Billion | -4.8 Million | -1.07 Billion | 16.2 Million | -21.35 Billion | 453.5 Million |
| Investment purchases | -362.6 Million | -10.75 Billion | -1.71 Billion | - | -21.5 Million | -5.1 Million |
| Sales/Maturities of investments | - | 997.1 Million | 793.9 Million | - | 275.2 Million | 762.7 Million |
| Other Investing Activities | -350 Million | 1.25 Billion | -115 Million | 438 Million | -4.4 Billion | -219.1 Million |
| Financing Cash Flow | -914.8 Million | -2.88 Billion | -2.94 Billion | 1.91 Billion | 23.53 Billion | -739.5 Million |
| Debt repayment | -781.3 Million | -1.39 Billion | -2.49 Billion | -8.32 Billion | -1.51 Billion | -306.8 Million |
| Dividends payments | -970.1 Million | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 9.4 Million | 13.1 Million | 36.6 Million | 11.79 Billion | 18.57 Billion | - |
| Other Financing Activities | -500 Thousand | -1.49 Billion | -482.3 Million | -1.55 Billion | 6.46 Billion | -432.7 Million |
| Accounts receivables | -1.08 Billion | 647.4 Million | 29.1 Million | 560.6 Million | -314.3 Million | -778 Million |
| Accounts payables | -401.3 Million | 987.4 Million | -447.8 Million | -4.77 Billion | -118.9 Million | 281.2 Million |
| Inventory | 59 Million | -148.7 Million | -75.6 Million | 172.5 Million | -120.4 Million | 22.6 Million |
| Other working capital | -161.7 Million | -679.8 Million | -811.1 Million | 283.4 Million | 165.2 Million | -7.1 Million |
| Cash at beginning of period | 1.36 Billion | 3.09 Billion | 6.26 Billion | 1.11 Billion | 3.21 Billion | 91.3 Million |
| Cash at end of period | 10.99 Billion | 427.5 Million | 3.09 Billion | 6.26 Billion | 1.11 Billion | 76 Million |
| Capital Expenditure | -7.78 Billion | -3.35 Billion | -5.53 Billion | -1.18 Billion | -900.9 Million | -1.15 Billion |
| Effect of forex changes on cash | -18.2 Million | 1.1 Million | - | 2.79 Billion | - | - |
| Net cash flow / Change in cash | 9.63 Billion | -2.66 Billion | -3.17 Billion | 5.15 Billion | -2.1 Billion | -15.3 Million |
| Free Cash Flow | 3.23 Billion | 8.73 Billion | 1.87 Billion | -5.6 Million | -130 Million | -267.8 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.36 Billion | 2.51 Billion | 10.57 Billion | 2.89 Billion | 2.76 Billion | 2.4 Billion |
| Depreciation & Amortization | - | - | 2.44 Billion | 609.6 Million | 578.8 Million | 558.2 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 496.2 Million | - | - | - |
| Change in working capital | - | - | -1.59 Billion | - | - | - |
| Other non-cash items | -2.36 Billion | -2.51 Billion | 5.92 Billion | -2.89 Billion | -2.76 Billion | -2.4 Billion |
| Investing Cash Flow | - | - | -14.38 Billion | - | - | - |
| Investments in PPE | - | - | -7.78 Billion | - | - | - |
| Acquisitions | - | - | -6.23 Billion | - | - | - |
| Investment purchases | - | - | -362.6 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -350 Million | - | - | - |
| Financing Cash Flow | - | - | -914.8 Million | - | - | - |
| Debt repayment | - | - | -781.3 Million | - | - | - |
| Dividends payments | - | - | -970.1 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 9.4 Million | - | - | - |
| Other Financing Activities | - | - | -500 Thousand | - | - | - |
| Accounts receivables | - | - | -1.08 Billion | - | - | - |
| Accounts payables | - | - | -401.3 Million | - | - | - |
| Inventory | - | - | 59 Million | - | - | - |
| Other working capital | - | - | -161.7 Million | - | - | - |
| Cash at beginning of period | - | - | 1.36 Billion | 17.91 Billion | 15.15 Billion | 1.36 Billion |
| Cash at end of period | - | - | 10.99 Billion | 2.89 Billion | 17.91 Billion | 2.4 Billion |
| Capital Expenditure | - | - | -7.78 Billion | - | - | - |
| Effect of forex changes on cash | - | - | -18.2 Million | - | - | - |
| Net cash flow / Change in cash | - | - | 9.63 Billion | -15.02 Billion | 2.76 Billion | 1.03 Billion |
| Free Cash Flow | - | - | 3.23 Billion | 2.89 Billion | 2.76 Billion | 2.4 Billion |
LTHIF
NGKIF
HCL-INSYS
9103
TDVXF
OKTA